Melanoma associated mutations in cyclin-dependent kinase 4 (CDK4), which were also classified as high penetrance mutations, seem to be very rare as only a few families were reported since the initial report in 1996 (zuoet al. 1996). This evidence concerns the gene CDK4 and melanoma.